{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:19:18Z","timestamp":1791933558965,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      resistance to series of anti-malarial drugs is a major challenge in efforts to control and\/or eliminate malaria globally. In 1998, following the widespread of chloroquine (CQ) resistant\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      , Ethiopia switched from CQ to sulfadoxine\u2013pyrimethamine (SP) and subsequently in 2004 from SP to artemether\u2013lumefantrine (AL) for the treatment of uncomplicated falciparum malaria. Data on the prevalence of CQ resistance markers after more than two decades of its removal is important to map the selection pressure behind the targets codons of interest. The present study was conducted to determine the prevalence of mutations in\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      K76T and\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y codons among malaria-infected patients from Adama, Olenchiti and Metehara sites of East Shewa zone, Oromia Regional State, Ethiopia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Finger-prick whole blood samples were collected on 3MM Whatman \u00ae filter papers from a total of 121 microscopically confirmed\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      infected patients. Extraction of parasite DNA was done by Chelex-100 method from dried blood spot (DBS). Genomic DNA template was used to amplify\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      K76T and\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y codons by nested PCR. Nested PCR products were subjected to\n                      <jats:italic>Artherobacter protophormiae-I<\/jats:italic>\n                      (\n                      <jats:italic>APoI<\/jats:italic>\n                      ) restriction enzyme digestion to determine mutations at codons 76 and 86 of\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      and\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      genes, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 83\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      isolates successfully genotyped for\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      K76T, 91.6% carried the mutant genotypes (76T). The prevalence of\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      76T was 95.7%, 92.5% and 84.5% in Adama, Metehara and Olenchiti, respectively. The prevalence of\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      76T mutations in three of the study sites showed no statistical significance difference (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20091.895; P\u2009=\u20090.388). On the other hand, of the 80\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      samples successfully amplified for\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      , all carried the wild-type genotypes (\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Although CQ officially has been ceased for the treatment of falciparum malaria for more than two decades in Ethiopia, greater proportions of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      clinical isolates circulating in the study areas carry the mutant 76T genotypes indicating the presence of indirect CQ pressure in the country. However, the return of\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86 wild-type allele may be favoured by the use of AL for the treatment of uncomplicated falciparum malaria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04304-5","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T12:04:14Z","timestamp":1665144254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia"],"prefix":"10.1186","volume":"21","author":[{"given":"Jifar","family":"Hassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezahegn Solomon","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunduma","family":"Dinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemu","family":"Golassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"4304_CR1","volume-title":"World Malaria Report 2021","author":"WHO","year":"2021","unstructured":"WHO. World Malaria Report 2021. Geneva: World Health Organization; 2021."},{"key":"4304_CR2","doi-asserted-by":"publisher","first-page":"668574","DOI":"10.3389\/fgene.2021.668574","volume":"12","author":"AT Roux","year":"2021","unstructured":"Roux AT, Maharaj L, Oyegoke O, Akoniyon OP, Adeleke MA, Maharaj R, et al. Chloroquine and sulfadoxine\u2013pyrimethamine resistance in sub-Saharan Africa\u2014a review. Front Genet. 2021;12:668574.","journal-title":"Front Genet"},{"key":"4304_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861\u201371.","journal-title":"Mol Cell"},{"key":"4304_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Pharm D, Ogobara K, Doumbo MD, Joseph F, et al. A molecular marker for chloroquine resistant falciparum malaria. N Ingl J Med. 2001;344:257\u201363.","journal-title":"N Ingl J Med"},{"key":"4304_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1475-2875-8-32","volume":"8","author":"ML Ibrahim","year":"2009","unstructured":"Ibrahim ML, Steenkste N, Khim N, Adam HH, Konate L, Coppee JY, et al. Field-based evidence of fast and global increase of Plasmodium falciparum drug resistance by DNA-microarrays and PCR\/RFLP in Niger. Malar J. 2009;8:32.","journal-title":"Malar J"},{"key":"4304_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12936-015-0783-3","volume":"14","author":"L Golassa","year":"2015","unstructured":"Golassa L, Kamugisha E, Ishengoma DS, Baraka V, Shayo A, Baliraine FN, et al. Identification of large variation in Pfcrt, Pfmdr-1 and Pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania. Malar J. 2015;14:264.","journal-title":"Malar J."},{"key":"4304_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12936-019-2977-6","volume":"18","author":"MN Ikegbunam","year":"2019","unstructured":"Ikegbunam MN, Nkonganyi CN, Thomas BN, Esimone CO, Velavan TP, Ojurongbe O. Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine. Malar J. 2019;18:343.","journal-title":"Malar J"},{"key":"4304_CR8","doi-asserted-by":"publisher","first-page":"e103848","DOI":"10.1371\/journal.pone.0103848","volume":"9","author":"SK Shrivastava","year":"2014","unstructured":"Shrivastava SK, Gupta RK, Mahanta J, Dubey ML. Correlation of molecular markers, Pfmdr1-N86Y and Pfcrt-K76T, with in vitro chloroquine resistant Plasmodium falciparum, isolated in the malaria endemic states of Assam and Arunachal Pradesh, Northeast India. PLoS ONE. 2014;9:e103848.","journal-title":"PLoS ONE"},{"key":"4304_CR9","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gna N, Uhlemann A, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"4304_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.20546\/ijcmas.2016.510.051","volume":"5","author":"G Singh","year":"2016","unstructured":"Singh G, Singh R, Urhekar AD, Rane K. Gene sequence polymorphisms mutations in Pfmdr-1 and Pfcrt-o genes of Plasmodium falciparum. Int J Curr Microbiol Appl Sci. 2016;5:451\u20138.","journal-title":"Int J Curr Microbiol Appl Sci."},{"key":"4304_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","volume":"93","author":"L Cui","year":"2015","unstructured":"Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. Antimalarial drug resistance: literature review and activities and findings of the ICEMR Network. Am J Trop Med Hyg. 2015;93:57\u201368.","journal-title":"Am J Trop Med Hyg"},{"key":"4304_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0035-9203(96)90322-3","volume":"44","author":"AN Tulu","year":"1996","unstructured":"Tulu AN, Webbeg RH, Schellenberg AJS, Bradley DJ. Failure of chloroquine treatment for malaria in the highlands of Ethiopia. Trans R Soc Trop Med Hyg. 1996;44:556\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4304_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpddr.2019.09.002","volume":"11","author":"E Hailemeskel","year":"2019","unstructured":"Hailemeskel E, Menberu T, Shumie G, Behaksra S, Chali W, Keffale M, et al. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. Int J Parasitol Drugs Drug Resist. 2019;11:8\u201312.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4304_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12936-015-0723-2","volume":"14","author":"A Heuchert","year":"2015","unstructured":"Heuchert A, Abduselam N, Zeynudin A, Eshetu T, Loscher T, Wieser A, et al. Molecular markers of anti-malarial drug resistance in Southwest Ethiopia over time: regional surveillance from 2006 to 2013. Malar J. 2015;14:208.","journal-title":"Malar J"},{"key":"4304_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1475-2875-13-244","volume":"13","author":"SK Mekonnen","year":"2014","unstructured":"Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J. 2014;13:244.","journal-title":"Malar J"},{"key":"4304_CR16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, Mukadam RAG, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870\u20135.","journal-title":"J Infect Dis"},{"key":"4304_CR17","doi-asserted-by":"publisher","first-page":"e0009781","DOI":"10.1371\/journal.pntd.0009781","volume":"15","author":"T Ketema","year":"2021","unstructured":"Ketema T, Bacha K, Getahun K, Del Portillo HA, Bassat Q. Plasmodium vivax epidemiology in Ethiopia 2000\u20132020: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15:e0009781.","journal-title":"PLoS Negl Trop Dis"},{"key":"4304_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12936-017-1944-3","volume":"16","author":"L Golassa","year":"2017","unstructured":"Golassa L, White MT. Population \u2013 level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre. Malar J. 2017;16:307.","journal-title":"Malar J"},{"key":"4304_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12936-021-03914-9","volume":"20","author":"T File","year":"2021","unstructured":"File T, Chekol T, Solomon G, Dinka H, Golassa L. Detection of high frequency of MAD20 allelic variants of Plasmodium falciparum merozoite surface protein 1 gene from Adama and its surroundings, Oromia,\u00a0Ethiopia. Malar J. 2021;20:385.","journal-title":"Malar J."},{"key":"4304_CR20","unstructured":"WHO. Basic Malaria Microscopy. Part I. Learner\u2019s guide, 2nd Edn. Geneva: World Health Organization; 2010."},{"key":"4304_CR21","doi-asserted-by":"publisher","first-page":"e0123630","DOI":"10.1371\/journal.pone.0123630","volume":"10","author":"D Nega","year":"2015","unstructured":"Nega D, Daniel D, Tefera T, Eshetu T. Prevalence and predictors of asymptomatic malaria parasitemia among pregnant women in the rural surroundings of Arbaminch town. PLoS ONE. 2015;10:e0123630.","journal-title":"PLoS ONE"},{"key":"4304_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1475-2875-11-251","volume":"11","author":"WM Atrosh","year":"2012","unstructured":"Atrosh WM, Al-Mekhalfi HM, Mahdy MAK, Surin J. The detection of Pfcrt and Pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia. Malar J. 2012;11:251.","journal-title":"Malar J"},{"key":"4304_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12936-021-03859-z","volume":"20","author":"MC Mulenga","year":"2021","unstructured":"Mulenga MC, Sitali L, Ciubotariu II, Hawela MB, Hamainza B. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia. Malar J. 2021;20:329.","journal-title":"Malar J"},{"key":"4304_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12936-021-03977-8","volume":"20","author":"G Fontecha","year":"2021","unstructured":"Fontecha G, Pinto A, Archaga O, Betancourth S, Escober L, Henr\u00edquez J, et al. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in Pfcrt and Pfmdr1 genes in isolates from Honduras and Nicaragua, 2018\u20132021. Malar J. 2021;20:465.","journal-title":"Malar J"},{"key":"4304_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mcp.2005.10.003","volume":"20","author":"MI Veiga","year":"2006","unstructured":"Veiga MI, Ferreira PE, Gil PJ. Multiplex PCR-RFLP methods for Pfcrt, Pfmdr1 and Pfdhfr mutations in Plasmodium falciparum. Mol Cell Probes. 2006;20:100\u20134.","journal-title":"Mol Cell Probes."},{"key":"4304_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1475-2875-10-214","volume":"10","author":"P Mula","year":"2011","unstructured":"Mula P, Fernandez-martinez A, Lucio A, De, Ramos JM, Reyes F, Gonzalez V, et al. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in Southern Ethiopia. Malar J. 2011;10:214.","journal-title":"Malar J"},{"key":"4304_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/PLMI.S259159","volume":"12","author":"F Jaleta","year":"2020","unstructured":"Jaleta F, Garoma G, Gerenfes T. Evaluation of malaria microscopy diagnosis performance in public hospitals of Eastern and Central part of Oromia Region, Ethiopia, 2019. Pathol Lab Med Int. 2020;12:1\u20138.","journal-title":"Pathol Lab Med Int"},{"key":"4304_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1475-2875-5-54","volume":"5","author":"M Schunk","year":"2006","unstructured":"Schunk M, Kumma WP, Miranda IB, Osman ME, Roewer S, Alano A, et al. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in Southern Ethiopia. Malar J. 2006;5:54.","journal-title":"Malar J"},{"key":"4304_CR29","unstructured":"MOH. Ethiopia Malaria Elimination Strategic Plan: 2021\u20132025. Ministry of Health; Addis Ababa, Ethiopia; 2020."},{"key":"4304_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12936-020-03192-x","volume":"19","author":"DM Yobi","year":"2020","unstructured":"Yobi DM, Kayiba NK, Mvumbi DM, Boreux R, Kabututu PZ, Situakibanza HNT, et al. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquine resistance and lack of amodiaquinoresistance. Malar J. 2020;19:121.","journal-title":"Malar J"},{"key":"4304_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1756-3305-4-94","volume":"4","author":"AM Al-Mekhlafi","year":"2011","unstructured":"Al-Mekhlafi AM, Mahdy MAK, Al-Mekhlafi HM, Azazy AA, Fong MY. High frequency of Plasmodium falciparum chloroquine resistance marker (Pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy. Parasit Vectors. 2011;4:94.","journal-title":"Parasit Vectors"},{"key":"4304_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/diseases9010006","volume":"9","author":"R Adam","year":"2021","unstructured":"Adam R, Mukhtar MM, Abubakar UF, Damudi HA, Muhammad A, Ibrahim SS. Polymorphism analysis of Pfmdr1 and Pfcrt from Plasmodium falciparum isolates in Northwestern Nigeria revealed the major markers associated with antimalarial resistance. Diseases. 2021;9:6.","journal-title":"Diseases"},{"key":"4304_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijpddr.2017.06.002","volume":"7","author":"S Das","year":"2017","unstructured":"Das S, Tripathy S, Chattopadhayay S, Das B, Kar Mahapatra S, Hati AK, et al. Progressive increase in point mutations associates chloroquine resistance: even after withdrawal of chloroquine use in India. IJP Drugs Drug Resist. 2017;7:251\u201361.","journal-title":"IJP Drugs Drug Resist"},{"key":"4304_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4269\/ajtmh.20-0415","volume":"104","author":"FT Johora","year":"2021","unstructured":"Johora FT, Elahi R, Nima MK, Hossain MS, Rashid H, Kibria MG, et al. Persistence of markers of chloroquine resistance in Plasmodium falciparum in Bangladesh. Am J Trop Med Hyg. 2021;104:276\u201382.","journal-title":"Am J Trop Med Hyg"},{"key":"4304_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12936-021-03713-2","volume":"20","author":"ER Ebel","year":"2021","unstructured":"Ebel ER, Reis F, Petrov DA, Beleza S. Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola. Malar J. 2021;20:175.","journal-title":"Malar J"},{"key":"4304_CR36","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AAR. Detection of mutations associated with artemisinin resistance at K13- propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"4304_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12936-020-03358-7","volume":"19","author":"W Chebore","year":"2020","unstructured":"Chebore W, Zhou Z, Westercamp N, Otieno K, Shi YP, Sergent SB, et al. Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in Western Kenya. Malar J. 2020;19:291.","journal-title":"Malar J"},{"key":"4304_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-020-03157-0","volume":"19","author":"B Balikagala","year":"2020","unstructured":"Balikagala B, Sakurai-Yatsushiro M, Tachibana SI, Ikeda M, Yamauchi M, Katuro OT, et al. Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda. Malar J. 2020;19:76.","journal-title":"Malar J"},{"key":"4304_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.actatropica.2014.03.030","volume":"136","author":"R Afoakwah","year":"2014","unstructured":"Afoakwah R, Boampong JN, Egyir-Yawson A, Nwaefuna EK, Verner ON, Asare KK. High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana. Acta Trop. 2014;136:32\u20136.","journal-title":"Acta Trop"},{"key":"4304_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/jabb\/2018\/v20i330078","volume":"20","author":"HA Edogun","year":"2019","unstructured":"Edogun HA, Daramola GO, Ojerinde AO, Esan CO, Adegbuyi AT. Prevalence of mutant alleles responsible for chloroquine resistance among Plasmodium falciparum isolates in North Central, Nigeria. J Adv Biol Biotechnol. 2019;20:1\u20138.","journal-title":"J Adv Biol Biotechnol"},{"key":"4304_CR41","doi-asserted-by":"publisher","first-page":"e0005806","DOI":"10.1371\/journal.pntd.0005806","volume":"11","author":"E Lo","year":"2017","unstructured":"Lo E, Hemming-schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, et al. Transmission dynamics of co-endemic Plasmodium vivax and Plasmodium falciparum in Ethiopia and prevalence of anti-malarial resistant genotypes. PLoS Negl Trop Dis. 2017;11:e0005806.","journal-title":"PLoS Negl Trop Dis"},{"key":"4304_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12936-016-1503-3","volume":"15","author":"SD Otienoburu","year":"2016","unstructured":"Otienoburu SD, Maiga-Ascofare O, Schramm B, Jullien V, Jones JJ, Zolia YM, et al. Selection of Plasmodium falciparum Pfcrt and Pfmdr1 polymorphisms after treatment with artesunate\u2013amodiaquine fixed dose combination or artemether\u2013lumefantrine in Liberia. Malar J. 2016;15:452.","journal-title":"Malar J"},{"key":"4304_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12936-021-03985-8","volume":"20","author":"KK Asare","year":"2021","unstructured":"Asare KK, Africa J, Mbata J, Opoku YK. The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana. Malar J. 2021;20:447.","journal-title":"Malar J"},{"key":"4304_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12936-021-03930-9","volume":"20","author":"A Chidimatembue","year":"2021","unstructured":"Chidimatembue A, Svigel SS, Mayor A, Aide P, Nhama A, Nhamussua L, et al. Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018. Malar J. 2021;20:398.","journal-title":"Malar J"},{"key":"4304_CR45","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jis747","volume":"207","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with Pfmdr1 polymorphisms. J Infect Dis. 2013;207:842\u20137.","journal-title":"J Infect Dis"},{"key":"4304_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Price RN, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for Plasmodium falciparum malaria after artemether\u2013lumefantrine and artesunate\u2013amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"4304_CR47","doi-asserted-by":"publisher","first-page":"e01949-20","DOI":"10.1128\/AAC.01949-20","volume":"65","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, Candido LM, Ferreira M, Caquece F. Continued low efficacy of artemether\u2013lumefantrine in Angola in 2019. Antimicrob Agents Chemother. 2021;65:e01949-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"4304_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12936-020-03506-z","volume":"19","author":"A Adamu","year":"2020","unstructured":"Adamu A, Jada MS, Haruna HMS, Yakubu BO, Ibrahim MA, Balogun EO, et al. Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether\u2013lumefantrine in the region. Malar J. 2020;19:439.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04304-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T13:07:24Z","timestamp":1665148044000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04304-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4304"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04304-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by Adama Science and Technology University research and ethical committee (certificate Reference No: RECSoANS\/BIO\/02\/2019). Permission latter was also obtained from Oromia Regional State Health Bureau.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declared that they do not have competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}